RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study ; volume:23 ; number:1 ; day:26 ; month:3 ; year:2024 ; pages:1-11 ; date:12.2024
Molecular cancer ; 23, Heft 1 (26.3.2024), 1-11, 12.2024
- Creator
-
Nelson, Blessie Elizabeth
Roszik, Jason
Ahmed, Jibran
Barretto, Carmelia Maria Noia
Nardo, Mirella
Campbell, Erick
Johnson, Amber M.
Piha-Paul, Sarina A.
Oliva, Isabella C. Glitza
Weathers, Shiao-Pei
Cabanillas, Maria
Javle, Milind
Meric-Bernstam, Funda
Subbiah, Vivek
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-024-01982-4
- URN
-
urn:nbn:de:101:1-2406121204275.958951803767
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nelson, Blessie Elizabeth
- Roszik, Jason
- Ahmed, Jibran
- Barretto, Carmelia Maria Noia
- Nardo, Mirella
- Campbell, Erick
- Johnson, Amber M.
- Piha-Paul, Sarina A.
- Oliva, Isabella C. Glitza
- Weathers, Shiao-Pei
- Cabanillas, Maria
- Javle, Milind
- Meric-Bernstam, Funda
- Subbiah, Vivek
- SpringerLink (Online service)
Other Objects (12)
Phospho-proteomic analysis of B-Raf complexes
Mutationsscreening von A-Raf und B-Raf in humanen Glioblastom-Tumorproben
B-Raf specific antibody responses in melanoma patients
Characterization of aberrant pathways across human cancers
B-Raf and the inhibitors: from bench to bedside
Aberrant Expression of Syndecan-1 in Cervical Cancers
RE | -RE- RE | RE | RE | RACE
Functional analysis of the B-raf and raf-1 proto oncogenes in B lymphocytes
Re RE
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : : a retrospective multicenter study
Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf
B-Raf regulation by the dimer interface and activation loop phosphorylation
Phospho-proteomic analysis of B-Raf complexes
Mutationsscreening von A-Raf und B-Raf in humanen Glioblastom-Tumorproben
B-Raf specific antibody responses in melanoma patients
Characterization of aberrant pathways across human cancers
B-Raf and the inhibitors: from bench to bedside
Aberrant Expression of Syndecan-1 in Cervical Cancers
RE | -RE- RE | RE | RE | RACE
Functional analysis of the B-raf and raf-1 proto oncogenes in B lymphocytes
Re RE
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : : a retrospective multicenter study
Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf
B-Raf regulation by the dimer interface and activation loop phosphorylation
Phospho-proteomic analysis of B-Raf complexes
Mutationsscreening von A-Raf und B-Raf in humanen Glioblastom-Tumorproben
B-Raf specific antibody responses in melanoma patients
Characterization of aberrant pathways across human cancers
B-Raf and the inhibitors: from bench to bedside
Aberrant Expression of Syndecan-1 in Cervical Cancers
RE | -RE- RE | RE | RE | RACE
Functional analysis of the B-raf and raf-1 proto oncogenes in B lymphocytes
Re RE
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : : a retrospective multicenter study
Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf